RM-191A by RR MedSciences for Neuropathic Pain (Neuralgia): Likelihood of Approval

RM-191A is under clinical development by RR MedSciences and currently in Phase II for Neuropathic Pain (Neuralgia).

Eating live microbe-rich foods linked to better heart health

Study reveals consuming foods rich in live microorganisms can improve cardiovascular health among US adults, suggesting a beneficial link between diet and heart health markers.

March 5, 2024

Unlocking Alzheimer’s secrets: Study pinpoints APOE4’s harmful effect on lipids

UNC School of Medicine researcher Sarah Cohen, PhD, and Ian Windham, a former PhD student from the Cohen lab, have made a new discovery about

February 10, 2024

Opinion | Doing Away With Needle Exchange Programs Won’t Prevent Drug Use

Assaf is an epidemiologist and postdoctoral fellow researching substance use, drug-related overdose, and harm reduction. A needle exchange program, also known as a syringe services

February 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.